Intercept Pharmaceuticals

About:

Intercept Pharmaceuticals develops small molecule drugs and therapeutics for the treatment of chronic fibrotic and metabolic diseases.

Website: http://www.interceptpharma.com

Twitter/X: InterceptPharma

Top Investors: OrbiMed, Balyasny Asset Management, Aisling Capital, Rodman & Renshaw, Genextra

Description:

Intercept Pharmaceuticals is a biopharmaceutical company, that engages in discovering and developing small molecule drugs and therapeutics for the treatment of chronic fibrotic and metabolic diseases. It offers INT-747, an FXR modulating agent that treats patients with chronic autoimmune liver diseases. The company's drug development programs also focus on modulating bile acid receptors, and amelioration of metabolic and hepatic functions in chronic liver diseases